Glucose

peroxisome proliferator activated receptor gamma ; Homo sapiens







320 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
51 29608487 Enhancing human cord blood hematopoietic stem cell engraftment by targeting nuclear hormone receptors. 2018 Jul 2
52 29662003 PPAR Agonists and Metabolic Syndrome: An Established Role? 2018 Apr 14 1
53 29686698 High Glucose Induces Autophagy through PPARγ-Dependent Pathway in Human Nucleus Pulposus Cells. 2018 4
54 29845188 lncRNA Ftx promotes aerobic glycolysis and tumor progression through the PPARγ pathway in hepatocellular carcinoma. 2018 Aug 1
55 29914059 Nuclear Receptor Regulation of Aquaglyceroporins in Metabolic Organs. 2018 Jun 15 2
56 30111834 The IRE1α-XBP1s pathway promotes insulin-stimulated glucose uptake in adipocytes by increasing PPARγ activity. 2018 Aug 15 1
57 30248999 Development of an In Vitro Screening Platform for the Identification of Partial PPARγ Agonists as a Source for Antidiabetic Lead Compounds. 2018 Sep 22 1
58 30404011 PPARγΔ5, a Naturally Occurring Dominant-Negative Splice Isoform, Impairs PPARγ Function and Adipocyte Differentiation. 2018 Nov 6 2
59 27320332 Retinoid X Receptor Ligands with Anti-Type 2 Diabetic Activity. 2017 2
60 27687006 Fatty acid-binding protein 1 is preferentially lost in microsatellite instable colorectal carcinomas and is immune modulated via the interferon γ pathway. 2017 Jan 1
61 27717959 Endotrophin, a multifaceted player in metabolic dysregulation and cancer progression, is a predictive biomarker for the response to PPARγ agonist treatment. 2017 Jan 1
62 27914122 Design, Synthesis, and Structure-Activity Relationships of Bavachinin Analogues as Peroxisome Proliferator-Activated Receptor γ Agonists. 2017 Jan 20 2
63 28277542 MicroRNA-27a promotes podocyte injury via PPARγ-mediated β-catenin activation in diabetic nephropathy. 2017 Mar 9 1
64 28461124 Pharmacological PPARγ modulation regulates sebogenesis and inflammation in SZ95 human sebocytes. 2017 Aug 15 1
65 28575810 Homology modeling and molecular docking studies on Type II diabetes complications reduced PPARγ receptor with various ligand molecules. 2017 Aug 1
66 28644880 O-GlcNAcylation mediates the control of cytosolic phosphoenolpyruvate carboxykinase activity via Pgc1α. 2017 1
67 29056962 Chiglitazar Preferentially Regulates Gene Expression via Configuration-Restricted Binding and Phosphorylation Inhibition of PPARγ. 2017 1
68 29222456 BMPs as new insulin sensitizers: enhanced glucose uptake in mature 3T3-L1 adipocytes via PPARγ and GLUT4 upregulation. 2017 Dec 8 1
69 29371958 Gestational diabetes mellitus is associated with decreased adipose and placenta peroxisome proliferator-activator receptor γ expression in a Chinese population. 2017 Dec 26 2
70 26632493 Fatty acids, eicosanoids and PPAR gamma. 2016 Aug 15 1
71 26930265 Attenuation of hyperglycemia-induced apoptotic signaling and anti-angiogenic milieu in cultured cytotrophoblast cells. 2016 May 1
72 26946260 Cystathionine γ lyase-hydrogen sulfide increases peroxisome proliferator-activated receptor γ activity by sulfhydration at C139 site thereby promoting glucose uptake and lipid storage in adipocytes. 2016 May 2
73 27035557 Monogenic Diabetes: What It Teaches Us on the Common Forms of Type 1 and Type 2 Diabetes. 2016 Jun 1
74 27268145 PPARγ signaling and emerging opportunities for improved therapeutics. 2016 Sep 2
75 27313447 Synthesis, activity, and docking study of phenylthiazole acids as potential agonists of PPARγ. 2016 2
76 27323819 Activation of PPARγ suppresses proliferation and induces apoptosis of esophageal cancer cells by inhibiting TLR4-dependent MAPK pathway. 2016 Jul 12 4
77 27422345 PPARG Post-translational Modifications Regulate Bone Formation and Bone Resorption. 2016 Aug 2
78 27508153 The effect of exercise training combined with PPARγ agonist on skeletal muscle glucose uptake and insulin sensitivity in induced diabetic obese Zucker rats. 2016 Jun 1
79 27698657 PPARγ as a Novel Therapeutic Target in Lung Cancer. 2016 1
80 25007880 PPARγ and PGC-1α as therapeutic targets in Parkinson's. 2015 Feb 1
81 25251562 Identification of PPARγ Agonists from Natural Sources Using Different In Silico Approaches. 2015 Apr 2
82 25335934 PPAR-γ promotes endothelial cell migration by inducing the expression of Sema3g. 2015 Apr 1
83 25410618 PPARγ is involved in the hyperglycemia-induced inflammatory responses and collagen degradation in human chondrocytes and diabetic mouse cartilages. 2015 Mar 1
84 25416646 PPARγ ligands and their therapeutic applications: a patent review (2008 - 2014). 2015 Feb 1
85 25430543 Pleiotropic role of PPARγ in intracerebral hemorrhage: an intricate system involving Nrf2, RXR, and NF-κB. 2015 Apr 2
86 25438608 The peroxisome proliferator-activated receptors in cardiovascular diseases: experimental benefits and clinical challenges. 2015 Dec 1
87 25450819 PPAR gamma gene--a review. 2015 Jan-Mar 2
88 25479590 Flightless-1, a novel transcriptional modulator of PPARγ through competing with RXRα. 2015 Mar 2
89 25641779 On the metabolically active form of metaglidasen: improved synthesis and investigation of its peculiar activity on peroxisome proliferator-activated receptors and skeletal muscles. 2015 Mar 2
90 25725372 Transmembrane tumor necrosis factor-alpha sensitizes adipocytes to insulin. 2015 May 5 2
91 25954810 Phosphorylation of PPARγ Affects the Collective Motions of the PPARγ-RXRα-DNA Complex. 2015 2
92 26047365 Molecular Recognition of PPARγ by Kinase Cdk5/p25: Insights from a Combination of Protein-Protein Docking and Adaptive Biasing Force Simulations. 2015 Jul 2 2
93 26181104 The Glucose Sensor ChREBP Links De Novo Lipogenesis to PPARγ Activity and Adipocyte Differentiation. 2015 Nov 1
94 26322090 Gestational diabetes mellitus is associated with increased leukocyte peroxisome proliferator-activated receptor γ expression. 2015 Aug 12 4
95 26414848 Identification of a New Type of Covalent PPARγ Agonist using a Ligand-Linking Strategy. 2015 Dec 18 2
96 26536161 Amorfrutins are efficient modulators of peroxisome proliferator-activated receptor gamma (PPARγ) with potent antidiabetic and anticancer properties: a patent evaluation of WO2014177593 A1. 2015 2
97 24200052 Interaction of genetic risk factors confers increased risk for metabolic syndrome: the role of peroxisome proliferator-activated receptor γ. 2014 Jan 2
98 24643342 Effects on metabolic markers are modified by PPARG2 and COX2 polymorphisms in infants randomized to fish oil. 2014 May 2
99 24692390 Phenotypic screening to identify small-molecule enhancers for glucose uptake: target identification and rational optimization of their efficacy. 2014 May 12 3
100 24705063 An alternate binding site for PPARγ ligands. 2014 Apr 7 1